RAD51D and intestinal cancer: In this case-control study, mutations in 8 genes (APC, ATM, MLH1, FANCD2, MSH3, MSH6, PMS1, and RAD51D) were found to be associated with bowel cancer and were present in 3.5% of patients with bowel cancer.